Coronavirus Update: Trump Tests Positive, US Pause Remains On AstraZeneca Vaccine
Plus: Gilead Takes Over Remdesivir Supply
Meanwhile, seven former US FDA commissioners issue joint plea for trust in the scientific integrity of the agency.
You may also be interested in...
Merck KGaA Exec On Innovating Vaccine Manufacturing To Tackle Outbreaks
The head of global vaccine and plasma segments, bioprocessing, at German multinational Merck discusses key aspects around evolving vaccine manufacturing to improve the efficiency and speed of response during a pandemic. Pre-existing manufacturing platforms, the executive says, could compress process development work and fast-track scale-up.
Coronavirus Update: Trial Of Lilly's Antibody Is Next To Be Paused
NIH study of monoclonal antibody therapy in combination with Gilead's remdesivir paused for safety reasons.
J&J Says It's Wait And See On COVID-19 Vaccine Delay, Outlines Rosier Outlook for 2021
It will be several days at least before more information is available about the unexpected illness in J&J's Phase III COVID-19 vaccine trial, the firm said during its third quarter financial call.